Bank of Nova Scotia
ONC

Bank of Nova Scotia’s BeOne Medicines Ltd ONC Stock Holding History

Bank of Nova Scotia’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,000
Closed -$573K – 1074
2020
Q3 		$573K Hold
2,000
– – ﹤0.01% 844
2020
Q2 		$377K Buy
2,000
+100
+5% +$16.3K ﹤0.01% 809
2020
Q1 		$234K Buy
1,900
+400
+27% +$62.6K ﹤0.01% 853
2019
Q4 		$249K Buy
+1,500
New +$249K ﹤0.01% 882

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Bank of Nova Scotia's ONC Position: Q4 2020 in Review

Bank of Nova Scotia sold out of BeOne Medicines Ltd (ONC) in Q4 2020, closing a stake of 2,000 shares — an estimated $573K sold.

Bank of Nova Scotia first reported a position in ONC in Q4 2019 and held it in 4 quarters. The position peaked at $573K in Q3 2020. 248 funds tracked by Wall St. Rank hold ONC as of Q4 2020.

  • Bank of Nova Scotia reported no remaining BeOne Medicines Ltd position as of Q4 2020 after selling out during the quarter.
  • Bank of Nova Scotia sold 2,000 BeOne Medicines Ltd shares in Q4 2020, an estimated $573K.
  • Bank of Nova Scotia first reported a position in BeOne Medicines Ltd in Q4 2019 and held it in 4 quarters.
  • Bank of Nova Scotia's BeOne Medicines Ltd position peaked at $573K in Q3 2020.
  • 248 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2020.

Based on Bank of Nova Scotia's 13F filing for Q4 2020, filed 11 Feb 2021.